190 related articles for article (PubMed ID: 25414476)
1. Rapid and equivalent systemic bioavailability of the antidotes HI-6 and dicobalt edetate via the intraosseous and intravenous routes.
Hill SL; Thomas SH; Flecknell PA; Thomas AA; Morris CM; Henderson D; Dunn M; Blain PG
Emerg Med J; 2015 Aug; 32(8):626-31. PubMed ID: 25414476
[TBL] [Abstract][Full Text] [Related]
2. Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration.
Murray DB; Eddleston M; Thomas S; Jefferson RD; Thompson A; Dunn M; Vidler DS; Clutton RE; Blain PG
Ann Emerg Med; 2012 Oct; 60(4):424-30. PubMed ID: 22738685
[TBL] [Abstract][Full Text] [Related]
3. Modest and variable efficacy of pre-exposure hydroxocobalamin and dicobalt edetate in a porcine model of acute cyanide salt poisoning.
Thompson A; Dunn M; Jefferson RD; Dissanayake K; Reed F; Gregson R; Greenhalgh S; Clutton RE; Blain PG; Thomas SH; Eddleston M
Clin Toxicol (Phila); 2020 Mar; 58(3):190-200. PubMed ID: 31389254
[No Abstract] [Full Text] [Related]
4. The efficacy and adverse effects of dicobalt edetate in cyanide poisoning.
Marrs TC; Thompson JP
Clin Toxicol (Phila); 2016 Sep; 54(8):609-14. PubMed ID: 27352227
[TBL] [Abstract][Full Text] [Related]
5. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration.
Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K
Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular versus Intraosseous Delivery of Nerve Agent Antidote Pralidoxime Chloride in Swine.
Uwaydah NI; Hoskins SL; Bruttig SP; Farrar H; Copper NC; Deyo DJ; Dubick MA; Kramer GC
Prehosp Emerg Care; 2016; 20(4):485-92. PubMed ID: 27158860
[TBL] [Abstract][Full Text] [Related]
7. Intraosseous administration of antidotes - a systematic review.
Elliott A; Dubé PA; Cossette-Côté A; Patakfalvi L; Villeneuve E; Morris M; Gosselin S
Clin Toxicol (Phila); 2017 Dec; 55(10):1025-1054. PubMed ID: 28644688
[TBL] [Abstract][Full Text] [Related]
8. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
Simons KJ; Briggs CJ
J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
[TBL] [Abstract][Full Text] [Related]
9. Intraosseous vascular access in disasters and mass casualty events: A review of the literature.
Burgert JM
Am J Disaster Med; 2016; 11(3):149-166. PubMed ID: 28134414
[TBL] [Abstract][Full Text] [Related]
10. HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.
Dadparvar M; Wagner S; Wien S; Kufleitner J; Worek F; von Briesen H; Kreuter J
Toxicol Lett; 2011 Sep; 206(1):60-6. PubMed ID: 21726608
[TBL] [Abstract][Full Text] [Related]
11. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
Spöhrer U; Thiermann H; Klimmek R; Eyer P
Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
[TBL] [Abstract][Full Text] [Related]
13. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration.
Lukey BJ; Woodard CL; Clark CR; McCluskey MP
J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of sternal intraossesous atropine administration in normovolemic and hypovolemic swine.
Cornell M; Kelbaugh J; Todd B; Christianson K; Grayson K; O'Sullivan J; Johnson D; Loughren M
Am J Disaster Med; 2016; 11(4):233-236. PubMed ID: 28140437
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Effects of Intraosseous and Intravenous 5% Albumin on Infusion Time and Hemodynamic Measures in a Swine Model of Hemorrhagic Shock.
Muir SL; Sheppard LB; Maika-Wilson A; Burgert JM; Garcia-Blanco J; Johnson AD; Coyner JL
Prehosp Disaster Med; 2016 Aug; 31(4):436-42. PubMed ID: 27210025
[TBL] [Abstract][Full Text] [Related]
16. Intraosseous versus intravenous infusion of hydroxocobalamin for the treatment of acute severe cyanide toxicity in a Swine model.
Bebarta VS; Pitotti RL; Boudreau S; Tanen DA
Acad Emerg Med; 2014 Nov; 21(11):1203-11. PubMed ID: 25377396
[TBL] [Abstract][Full Text] [Related]
17. Intraosseous line placement for antidote injection by first responders and receivers wearing personal protective equipment.
Borron SW; Arias JC; Bauer CR; Philbeck T; Hass P; Lawson W; Montez D; Fernández M; Jung I; Gordon DJ
Am J Emerg Med; 2011 May; 29(4):373-81. PubMed ID: 20825804
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector.
Nyberg AG; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Palmer L; Persson SA
Biopharm Drug Dispos; 1995 Nov; 16(8):635-51. PubMed ID: 8573684
[TBL] [Abstract][Full Text] [Related]
19. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
Kassa J; Kunesova G
Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability and disposition kinetics of HI-6 in Beagle dogs.
Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H
Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
